DK0652287T3 - Poxvirale vektorer og deres anvendelse som en vaccine mod felin infektiøs peritonotos-virussygdom - Google Patents

Poxvirale vektorer og deres anvendelse som en vaccine mod felin infektiøs peritonotos-virussygdom

Info

Publication number
DK0652287T3
DK0652287T3 DK94306917T DK94306917T DK0652287T3 DK 0652287 T3 DK0652287 T3 DK 0652287T3 DK 94306917 T DK94306917 T DK 94306917T DK 94306917 T DK94306917 T DK 94306917T DK 0652287 T3 DK0652287 T3 DK 0652287T3
Authority
DK
Denmark
Prior art keywords
feline infectious
vaccine against
peritonotosis
virus disease
against feline
Prior art date
Application number
DK94306917T
Other languages
Danish (da)
English (en)
Inventor
Terri Wasmoen
Lloyd Chavez
Hsien-Jue Chu
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK0652287T3 publication Critical patent/DK0652287T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/819Viral vaccine for feline species, e.g. cats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK94306917T 1993-09-22 1994-09-21 Poxvirale vektorer og deres anvendelse som en vaccine mod felin infektiøs peritonotos-virussygdom DK0652287T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12551693A 1993-09-22 1993-09-22

Publications (1)

Publication Number Publication Date
DK0652287T3 true DK0652287T3 (da) 2003-04-07

Family

ID=22420074

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94306917T DK0652287T3 (da) 1993-09-22 1994-09-21 Poxvirale vektorer og deres anvendelse som en vaccine mod felin infektiøs peritonotos-virussygdom

Country Status (13)

Country Link
US (2) US5656275A (de)
EP (1) EP0652287B1 (de)
JP (2) JPH07184662A (de)
AT (1) ATE233821T1 (de)
AU (1) AU680531B2 (de)
CA (1) CA2132374C (de)
DE (1) DE69432207T2 (de)
DK (1) DK0652287T3 (de)
ES (1) ES2188605T3 (de)
NZ (1) NZ264518A (de)
PT (1) PT652287E (de)
SG (1) SG55095A1 (de)
TW (1) TW377373B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202225B1 (en) * 1993-10-15 2007-04-10 Emanuele R Martin Therapeutic delivery compositions and methods of use thereof
US20020123476A1 (en) * 1991-03-19 2002-09-05 Emanuele R. Martin Therapeutic delivery compositions and methods of use thereof
US6241989B1 (en) * 1991-07-09 2001-06-05 Cornell Research Foundation, Inc. Recombinant multivalent viral vaccine
US7087234B1 (en) * 1991-07-09 2006-08-08 Cornell Research Foundation, Inc. Recombinant multivalent viral vaccine
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US5858373A (en) * 1995-12-01 1999-01-12 Virogenetics Corporation Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them
FR2751223B1 (fr) * 1996-07-19 1998-12-04 Rhone Merieux Formule de vaccin polynucleotidique felin
AU5597998A (en) * 1996-12-04 1998-06-29 Heska Corporation Recombinant plague vaccine
AU7350798A (en) * 1997-04-29 1998-11-24 Universiteit Utrecht Corona virus-like particles as tools for vaccination and therapy
US6106841A (en) * 1998-02-04 2000-08-22 Heska Corporation Delivery method for recombinant raccoon poxvirus
US20050161884A1 (en) * 1998-02-17 2005-07-28 Au-Yeung Chi F. Method of and apparatus for playing a card game
US7279168B2 (en) 1998-05-01 2007-10-09 Texas A & M University System Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof
IL139372A0 (en) * 1998-05-01 2001-11-25 Schering Plough Ltd Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
DE60209345T2 (de) 2001-03-08 2006-08-03 Akzo Nobel N.V. Leporipox-basierende vektorvakzine
US7255986B2 (en) * 2002-01-31 2007-08-14 The Board Of Trustees Operating Michigan State University Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets
JP4242607B2 (ja) * 2002-07-04 2009-03-25 学校法人北里研究所 ネコ伝染性腹膜炎ワクチン
CA2681183A1 (en) * 2007-05-30 2008-12-11 Wyeth Raccoon poxvirus expressing genes of feline antigens

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES486442A0 (es) * 1978-11-30 1980-12-16 Wellcome Found Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
US4293653A (en) * 1979-04-12 1981-10-06 Horzinek Marian C Method for propagating feline infectious peritonitis virus
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
EP0264979A1 (de) * 1986-09-05 1988-04-27 Duphar International Research B.V Proteine und Peptide, wirksam wie Antigen und Impfstoffe gegen das infektiöse Peritonitisvirus der Felides (FIPV)
US5266313A (en) * 1987-02-03 1993-11-30 The United States Of America As Represented By The Department Of Health And Human Services Raccoon poxvirus as a gene expression and vaccine vector for genes of rabies virus and other organisms
IL87911A0 (en) * 1987-10-01 1989-03-31 Norden Lab Inc Vaccine for protection of cats against feline infectious peritonitis
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
CA2011025A1 (en) * 1989-03-01 1990-09-01 Terry R. Beardsley Feline infectious peritonitis vaccine
CA2020740A1 (en) * 1989-07-12 1991-01-13 Harry Vennema Antigenically active proteins/peptides, and feline infectious peritonitis virus (fipv)-vaccines
US5242686A (en) * 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
NZ240558A (en) * 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
AU2347692A (en) * 1991-07-09 1993-02-11 Cornell Research Foundation Inc. Recombinant viral vaccine

Also Published As

Publication number Publication date
AU7411694A (en) 1995-04-06
US5770211A (en) 1998-06-23
EP0652287A2 (de) 1995-05-10
JPH07184662A (ja) 1995-07-25
TW377373B (en) 1999-12-21
JP2005336206A (ja) 2005-12-08
DE69432207T2 (de) 2003-11-13
DE69432207D1 (de) 2003-04-10
EP0652287B1 (de) 2003-03-05
NZ264518A (en) 1996-06-25
SG55095A1 (en) 1998-12-21
PT652287E (pt) 2003-06-30
CA2132374A1 (en) 1995-03-23
EP0652287A3 (de) 1997-06-11
CA2132374C (en) 2005-05-17
US5656275A (en) 1997-08-12
ES2188605T3 (es) 2003-07-01
ATE233821T1 (de) 2003-03-15
AU680531B2 (en) 1997-07-31

Similar Documents

Publication Publication Date Title
DK0652287T3 (da) Poxvirale vektorer og deres anvendelse som en vaccine mod felin infektiøs peritonotos-virussygdom
AR003425A1 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de poxvirus para preparar una vacuna util para evitar o para disminuir la enfermedad causada por el virus de inmunodeficiencia felina (fiv)
ATE334216T1 (de) Impstoff gegen felines immunodefizienz-virus
ATE420190T1 (de) Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen
DE69829668D1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
DK0587780T4 (da) Smitstof, som forårsager Mystery Swine Disease,vaccinepræparater og diagnostiske sæt
MX9202512A (es) Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus.
DK0661999T3 (da) Vacciner mod felint immundefekt virus (FIV)
FR2828405B1 (fr) Vaccin anti-coronavirus
AU6683400A (en) Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat
DK0831899T3 (da) Rekombinant koppevirus-calicivirus-præparater og anvendelser
BR0310020A (pt) Expressão de genes no vìrus da vacìnia modificado ancara por uso do promotor de ati de vacìnia
FR2769916B1 (fr) Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
HUP0204176A2 (hu) PRRSV rekombináns virulencia gyengítése
FI953371A (fi) TBE-virusinfektiota vastaan tähtäävään immunisointiin tarkoitetut parannetut rokotteet sekä menetelmä niiden valmistamiseksi
AU2003281917A8 (en) Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats
WO2001049712A3 (en) Vaccine against isav (infectious salmon anaemia virus)
CA2351010A1 (en) A broad spectrum infectious bursal disease virus vaccine
NO942075L (no) Rekombinante virus omfattende kunstig proteolytisk spaltingssete
ATE473013T1 (de) Induzierte immunantwort gegen den katzen- immunschwäche-virus
TH44441A (th) วัคซีนไวรัสไข้เหลืองชนิดรีคอมบิแนนท์ที่ได้กลับคืนจาก cDNA ที่ติดเชื้อ
TH31605A (th) รีคอมบิแนนท์แรคคูนพอกซ์ไวรัสและการใช้มันต่อการติดเชื้อไวรัสก่อโรคภูมิพร่องในแมว
TH62970A (th) วัคซีนไวรัสโรคเบอร์ซาอักเสบติดต่อชนิดบรอดสเปคตรัม (broad spectrum)